Tumor Biology

, Volume 36, Issue 11, pp 8853–8860 | Cite as

Effect of expressions of tumor necrosis factor α and interleukin 1B on peritoneal metastasis of gastric cancer

  • Lin Guo
  • Jin-Lei Ou
  • Tong Zhang
  • Liang Ma
  • Long-Fei Qu
Research Article

Abstract

Our study aimed to investigate effect of expressions of tumor necrosis factor α (TNF-α) and interleukin 1B (IL-1B) on peritoneal metastasis of gastric cancer (GC). From June 2012 to June 2014, a total of 60 patients with advanced peritoneal metastasis from GC were collected from Department of Gastrointestinal and Nutriology Surgery at Shengjing Hospital of China Medical University. Furthermore, 60 GC patients without peritoneal metastasis were enrolled as controls. Immunohistochemistry was performed to test TNF-α and IL-1B expression, and logistic regression analysis was employed for evaluating risk factors for peritoneal metastasis of GC. Our results showed that TNF-α expression in metastatic group and non-metastatic group was significantly different (P = 0.043), but no significant difference was found in IL-1B expression between two groups (P = 0.261). In addition, TNF-α expression in metastatic group and non-metastatic group was associated with tumor size, depth of invasion, the degree of differentiation (all P < 0.05). Logistic regression analysis indicated that tumor size, depth of invasion, the degree of differentiation and TNF-α expression were risk factors for peritoneal metastasis of GC (all P < 0.05). Our study found that TNF-α expression may play a vital role in peritoneal metastasis of GC, while IL-1B expression might not be correlated with peritoneal metastasis.

Keywords

Gastric cancer Peritoneal metastasis Tumor necrosis factor α Interleukin 1B Immunohistochemistry Tumor size 

Notes

Acknowledgments

We are grateful to our instructors for their valuable advice. We also thank the reviewers for their precious comments on this paper.

Conflicts of interest

None

Authors’ contributions

L Guo designed the study. JL Ou conceived and supervised the study. T Zhang performed the examination and the analysis. L Ma performed the statistical analysis. LF Qu interpreted the results. L Guo drafted and revised the paper. All authors read and approved the final paper.

References

  1. 1.
    Camargo MC, Freedman ND, Hollenbeck AR, Abnet CC, Rabkin CS. Height, weight, and body mass index associations with gastric cancer subsites. Gastric Cancer. 2014;17(3):463–8.CrossRefPubMedGoogle Scholar
  2. 2.
    Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014;23(5):700–13.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Camargo MC, Koriyama C, Matsuo K, Kim WH, Herrera-Goepfert R, Liao LM, et al. Case-case comparison of smoking and alcohol risk associations with epstein-barr virus-positive gastric cancer. Int J Cancer. 2014;134(4):948–53.CrossRefPubMedGoogle Scholar
  4. 4.
    Buckland G, Travier N, Huerta JM, Bueno-de-Mesquita HB, Siersema PD, Skeie G, et al. Healthy lifestyle index and risk of gastric adenocarcinoma in the epic cohort study. Int J Cancer. 2014Google Scholar
  5. 5.
    Ema A, Yamashita K, Sakuramoto S, Wang G, Mieno H, Nemoto M, et al. Lymph node ratio is a critical prognostic predictor in gastric cancer treated with s-1 chemotherapy. Gastric Cancer. 2014;17(1):67–75.CrossRefPubMedGoogle Scholar
  6. 6.
    Kim HH, Han SU, Kim MC, Hyung WJ, Kim W, Lee HJ, et al. Long-term results of laparoscopic gastrectomy for gastric cancer: a large-scale case-control and case-matched korean multicenter study. J Clin Oncol. 2014;32(7):627–33.CrossRefPubMedGoogle Scholar
  7. 7.
    Yao K, Doyama H, Gotoda T, Ishikawa H, Nagahama T, Yokoi C, et al. Diagnostic performance and limitations of magnifying narrow-band imaging in screening endoscopy of early gastric cancer: a prospective multicenter feasibility study. Gastric Cancer. 2014;17(4):669–79.CrossRefPubMedGoogle Scholar
  8. 8.
    Ojetti V, Persiani R, Cananzi FC, Sensi C, Piscaglia AC, Saulnier N, et al. Cdna-microarray analysis as a new tool to predict lymph node metastasis in gastric cancer. World J Surg. 2014;38(8):2058–64.CrossRefPubMedGoogle Scholar
  9. 9.
    Kodera Y, Fujitani K, Fukushima N, Ito S, Muro K, Ohashi N, et al. Surgical resection of hepatic metastasis from gastric cancer: a review and new recommendation in the japanese gastric cancer treatment guidelines. Gastric Cancer. 2014;17(2):206–12.CrossRefPubMedGoogle Scholar
  10. 10.
    Chen WL, Shen CL, Chang YM, Hsieh CM, Chang CK, Hsian He H, et al. Pulmonary metastatic gastric cancer mimicking a giant mediastinal cyst. Ann Thorac Surg. 2014;98(1):329–31.CrossRefPubMedGoogle Scholar
  11. 11.
    Turkoz FP, Solak M, Kilickap S, Ulas A, Esbah O, Oksuzoglu B, et al. Bone metastasis from gastric cancer: the incidence, clinicopathological features, and influence on survival. J Gastric Cancer. 2014;14(3):164–72.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Kikuchi H, Kamiya K, Hiramatsu Y, Miyazaki S, Yamamoto M, Ohta M, et al. Laparoscopic narrow-band imaging for the diagnosis of peritoneal metastasis in gastric cancer. Ann Surg Oncol. 2014;21(12):3954–62.CrossRefPubMedGoogle Scholar
  13. 13.
    Okugawa Y, Toiyama Y, Hur K, Toden S, Saigusa S, Tanaka K, et al. Metastasis-associated long non-coding rna drives gastric cancer development and promotes peritoneal metastasis. Carcinogenesis. 2014;35(12):2731–9.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Yun HW, Shim KN. Role of 18F 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies. Korean J Gastroenterol. 2013;61(6):303–6.CrossRefPubMedGoogle Scholar
  15. 15.
    Thomassen I, van Gestel YR, van Ramshorst B, Luyer MD, Bosscha K, Nienhuijs SW, et al. Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors. Int J Cancer. 2014;134(3):622–8.CrossRefPubMedGoogle Scholar
  16. 16.
    Okabe H, Ueda S, Obama K, Hosogi H, Sakai Y. Induction chemotherapy with s-1 plus cisplatin followed by surgery for treatment of gastric cancer with peritoneal dissemination. Ann Surg Oncol. 2009;16(12):3227–36.CrossRefPubMedGoogle Scholar
  17. 17.
    Ishigami H, Kitayama J, Kaisaki S, Yamaguchi H, Yamashita H, Emoto S, et al. Phase I study of biweekly intravenous paclitaxel plus intraperitoneal cisplatin and paclitaxel for gastric cancer with peritoneal metastasis. Oncology. 2010;79(3-4):269–72.CrossRefPubMedGoogle Scholar
  18. 18.
    Glockzin G, Schlitt HJ, Piso P. Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol. 2009;7:5.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Bigatto V, De Bacco F, Casanova E, Reato G, Lanzetti L, Isella C, et al. Tnf-alpha promotes invasive growth through the met signaling pathway. Mol Oncol. 2015;9(2):377–88.CrossRefPubMedGoogle Scholar
  20. 20.
    Balkwill F. Tumour necrosis factor and cancer. Nat Rev Cancer. 2009;9(5):361–71.CrossRefPubMedGoogle Scholar
  21. 21.
    Keerthy HK, Mohan CD, Sivaraman Siveen K, Fuchs JE, Rangappa S, Sundaram MS, et al. Novel synthetic biscoumarins target tumor necrosis factor-alpha in hepatocellular carcinoma in vitro and in vivo. J Biol Chem. 2014;289(46):31879–90.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Kagoya Y, Yoshimi A, Kataoka K, Nakagawa M, Kumano K, Arai S, et al. Positive feedback between nf-kappab and tnf-alpha promotes leukemia-initiating cell capacity. J Clin Invest. 2014;124(2):528–42.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Yu L, Mu Y, Sa N, Wang H, Xu W. Tumor necrosis factor alpha induces epithelial-mesenchymal transition and promotes metastasis via nf-kappab signaling pathway-mediated twist expression in hypopharyngeal cancer. Oncol Rep. 2014;31(1):321–7.PubMedGoogle Scholar
  24. 24.
    Zhu F, Zhao H, Tian X, Meng X. Association between tumor necrosis factor-alpha rs1800629 polymorphism and risk of gastric cancer: a meta-analysis. Tumour Biol. 2014;35(3):1799–803.CrossRefPubMedGoogle Scholar
  25. 25.
    Vendramini-Costa DB, Carvalho JE. Molecular link mechanisms between inflammation and cancer. Curr Pharm Des. 2012;18(26):3831–52.CrossRefPubMedGoogle Scholar
  26. 26.
    Laddha NC, Dwivedi M, Mansuri MS, Singh M, Patel HH, Agarwal N, et al. Association of neuropeptide y (npy), interleukin-1b (il1b) genetic variants and correlation of il1b transcription levels with vitiligo susceptibility. PLoS One. 2014;9(9), e107020.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Kutikhin AG, Yuzhalin AE, Volkov AN, Zhivotovskiy AS, Brusina EB. Correlation between genetic polymorphisms within il-1b and tlr4 genes and cancer risk in a Russian population: a case-control study. Tumour Biol. 2014;35(5):4821–30.CrossRefPubMedGoogle Scholar
  28. 28.
    Kim J, Kim JW, Kim Y, Lee KA. Differential association of rantes-403 and il-1b-1464 polymorphisms on histological subtypes in male Korean patients with gastric cancer. Tumour Biol. 2014;35(4):3765–70.CrossRefPubMedGoogle Scholar
  29. 29.
    Paik JH, Choe G, Kim H, Choe JY, Lee HJ, Lee CT, et al. Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: correlation with fluorescence in situ hybridization. J Thorac Oncol. 2011;6(3):466–72.CrossRefPubMedGoogle Scholar
  30. 30.
    Yang XJ, Huang CQ, Suo T, Mei LJ, Yang GL, Cheng FL, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase iii randomized clinical trial. Ann Surg Oncol. 2011;18(6):1575–81.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Cheon SH, Rha SY, Jeung HC, Im CK, Kim SH, Kim HR, et al. Survival benefit of combined curative resection of the stomach (d2 resection) and liver in gastric cancer patients with liver metastases. Ann Oncol. 2008;19(6):1146–53.CrossRefPubMedGoogle Scholar
  32. 32.
    Tsujimoto H, Ichikura T, Ono S, Sugasawa H, Hiraki S, Sakamoto N, et al. Outcomes for patients following hepatic resection of metastatic tumors from gastric cancer. Hepatol Int. 2010;4(1):406–13.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Yokoe T, Toiyama Y, Okugawa Y, Tanaka K, Ohi M, Inoue Y, et al. Kap1 is associated with peritoneal carcinomatosis in gastric cancer. Ann Surg Oncol. 2010;17(3):821–8.CrossRefPubMedGoogle Scholar
  34. 34.
    Iwatsuki M, Fukagawa T, Mimori K, Nakanishi H, Ito S, Ishii H, et al. Bone marrow and peripheral blood expression of id1 in human gastric carcinoma patients is a bona fide indicator of lymph node and peritoneal metastasis. Br J Cancer. 2009;100(12):1937–42.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Iwasa S, Yanagawa T, Fan J, Katoh R. Expression of cxcr4 and its ligand sdf-1 in intestinal-type gastric cancer is associated with lymph node and liver metastasis. Anticancer Res. 2009;29(11):4751–8.PubMedGoogle Scholar
  36. 36.
    Miyagawa K, Sakakura C, Nakashima S, Yoshikawa T, Fukuda K, Kin S, et al. Overexpression of regiv in peritoneal dissemination of gastric cancer and its potential as a novel marker for the detection of peritoneal micrometastasis. Anticancer Res. 2008;28(2B):1169–79.PubMedGoogle Scholar
  37. 37.
    Kim SJ, Kim HH, Kim YH, Hwang SH, Lee HS, do Park J, et al. Peritoneal metastasis: detection with 16- or 64-detector row ct in patients undergoing surgery for gastric cancer. Radiology. 2009;253(2):407–15.CrossRefPubMedGoogle Scholar
  38. 38.
    Watanabe T, Hashimoto T, Sugino T, Soeda S, Nishiyama H, Morimura Y, et al. Production of il1-beta by ovarian cancer cells induces mesothelial cell beta1-integrin expression facilitating peritoneal dissemination. J Ovarian Res. 2012;5(1):7.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Tahara T, Shibata T, Nakamura M, Yamashita H, Yoshioka D, Okubo M, et al. Effect of il-1beta and tnf-alpha polymorphisms on the prognosis and survival of gastric cancer patients. Clin Exp Med. 2011;11(4):211–7.CrossRefPubMedGoogle Scholar
  40. 40.
    Wu Y, Zhou BP. Tnf-alpha/nf-kappab/snail pathway in cancer cell migration and invasion. Br J Cancer. 2010;102(4):639–44.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Choo MK, Sakurai H, Kim DH, Saiki I. A ginseng saponin metabolite suppresses tumor necrosis factor-alpha-promoted metastasis by suppressing nuclear factor-kappab signaling in murine colon cancer cells. Oncol Rep. 2008;19(3):595–600.PubMedGoogle Scholar
  42. 42.
    Kim S, Choi MG, Lee HS, Lee SK, Kim SH, Kim WW, et al. Silibinin suppresses tnf-alpha-induced mmp-9 expression in gastric cancer cells through inhibition of the mapk pathway. Molecules. 2009;14(11):4300–11.CrossRefPubMedGoogle Scholar
  43. 43.
    Popivanova BK, Kitamura K, Wu Y, Kondo T, Kagaya T, Kaneko S, et al. Blocking tnf-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest. 2008;118(2):560–70.PubMedPubMedCentralGoogle Scholar
  44. 44.
    Techasen A, Namwat N, Loilome W, Bungkanjana P, Khuntikeo N, Puapairoj A, et al. Tumor necrosis factor-alpha (tnf-alpha) stimulates the epithelial-mesenchymal transition regulator snail in cholangiocarcinoma. Med Oncol. 2012;29(5):3083–91.CrossRefPubMedGoogle Scholar
  45. 45.
    Ho MY, Tang SJ, Chuang MJ, Cha TL, Li JY, Sun GH, et al. Tnf-alpha induces epithelial-mesenchymal transition of renal cell carcinoma cells via a gsk3beta-dependent mechanism. Mol Cancer Res. 2012;10(8):1109–19.CrossRefPubMedGoogle Scholar
  46. 46.
    Oguma K, Oshima H, Aoki M, Uchio R, Naka K, Nakamura S, et al. Activated macrophages promote wnt signalling through tumour necrosis factor-alpha in gastric tumour cells. EMBO J. 2008;27(12):1671–81.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2015

Authors and Affiliations

  • Lin Guo
    • 1
  • Jin-Lei Ou
    • 1
  • Tong Zhang
    • 1
  • Liang Ma
    • 1
  • Long-Fei Qu
    • 1
  1. 1.Department of Gastrointestinal and Nutriology SurgeryShengjing Hospital of China Medical UniversityShenyangChina

Personalised recommendations